This HTML5 document contains 43 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
dctermshttp://purl.org/dc/terms/
n7http://linked.opendata.cz/resource/domain/vavai/riv/tvurce/
n12http://linked.opendata.cz/ontology/domain/vavai/
shttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
n3http://linked.opendata.cz/ontology/domain/vavai/riv/
n2http://linked.opendata.cz/resource/domain/vavai/vysledek/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n14http://linked.opendata.cz/ontology/domain/vavai/riv/klicoveSlovo/
n10http://linked.opendata.cz/ontology/domain/vavai/riv/duvernostUdaju/
xsdhhttp://www.w3.org/2001/XMLSchema#
n13http://linked.opendata.cz/resource/domain/vavai/vysledek/RIV%2F00064203%3A_____%2F07%3A2897%21RIV12-MZ0-00064203/
n15http://linked.opendata.cz/ontology/domain/vavai/riv/jazykVysledku/
n6http://linked.opendata.cz/ontology/domain/vavai/riv/aktivita/
n17http://linked.opendata.cz/ontology/domain/vavai/riv/obor/
n16http://linked.opendata.cz/ontology/domain/vavai/riv/druhVysledku/
n9http://reference.data.gov.uk/id/gregorian-year/

Statements

Subject Item
n2:RIV%2F00064203%3A_____%2F07%3A2897%21RIV12-MZ0-00064203
rdf:type
n12:Vysledek skos:Concept
rdfs:seeAlso
http://www.ncbi.nlm.nih.gov/pubmed/18219838
dcterms:description
BACKGROUND: Indacaterol is a novel, inhaled, once-daily beta2-agonist. OBJECTIVE: To investigate the safety and tolerability of indacaterol at doses of 400 and 800 microg/d. METHODS: Randomized, double-blind, placebo-controlled, parallel-group, multicenter, 28-day study. BACKGROUND: Indacaterol is a novel, inhaled, once-daily beta2-agonist. OBJECTIVE: To investigate the safety and tolerability of indacaterol at doses of 400 and 800 microg/d. METHODS: Randomized, double-blind, placebo-controlled, parallel-group, multicenter, 28-day study.
dcterms:title
Tolerability of indacaterol, a novel once-daily beta(2)-agonist, in patients with asthma: a randomized, placebo-controlled, 28-day safety study Tolerability of indacaterol, a novel once-daily beta(2)-agonist, in patients with asthma: a randomized, placebo-controlled, 28-day safety study
skos:prefLabel
Tolerability of indacaterol, a novel once-daily beta(2)-agonist, in patients with asthma: a randomized, placebo-controlled, 28-day safety study Tolerability of indacaterol, a novel once-daily beta(2)-agonist, in patients with asthma: a randomized, placebo-controlled, 28-day safety study
skos:notation
RIV/00064203:_____/07:2897!RIV12-MZ0-00064203
n3:aktivita
n6:V
n3:aktivity
V
n3:cisloPeriodika
6
n3:dodaniDat
n9:2012
n3:domaciTvurceVysledku
n7:9066918
n3:druhVysledku
n16:J
n3:duvernostUdaju
n10:S
n3:entitaPredkladatele
n13:predkladatel
n3:idSjednocenehoVysledku
455304
n3:idVysledku
RIV/00064203:_____/07:2897
n3:jazykVysledku
n15:eng
n3:klicovaSlova
Asthma+ long-acting beta-2 agonist; safety
n3:klicoveSlovo
n14:Asthma%2B%20long-acting%20beta-2%20agonist n14:safety
n3:kodStatuVydavatele
US - Spojené státy americké
n3:kontrolniKodProRIV
[F42289B41E6F]
n3:nazevZdroje
Annals of Allergy Asthma & Immunology
n3:obor
n17:FC
n3:pocetDomacichTvurcuVysledku
1
n3:pocetTvurcuVysledku
8
n3:rokUplatneniVysledku
n9:2007
n3:svazekPeriodika
99
n3:tvurceVysledku
Beier, Jutta Higgins, Mark Yang, William H Martinot, Jean Benoit Magula, Daniel Pohunek, Petr Cameron, Ray Owen, Roger
n3:wos
000251823000014
s:issn
1081-1206
s:numberOfPages
7